Healthcare & Biotech Expert
Marc Lichtenfeld is the Director of Research for Access Research Group and Healthcare Specialist for White Cap Research and White Cap Report’s mid-month issue called Xcelerated Profits Report.
After starting out as a trader at Carlin Equities, Marc moved onto the contrarian Avalon Research Group as a Senior Analyst. He also obtained his NASD Series 86 & 87 licenses (required for all sell-side analysts). At Weiss Research, he co-managed the Real Wealth Portfolio and beat the S&P 500 by 17% over a six month period.
Marc joined the team following a successful spell as Senior Columnist at TheStreet.com. A contrarian investor by nature, Marc loves to shoot holes in conventional thinking and take profits where nobody else is looking. He’s broken several major stories on biotech companies and his investment approach blends thorough fundamental research with the timing tools of technical analysis.
He’s currently in the final stages of obtaining his Chartered Market Technician credential.
Most Recent Articles:
- Wall Street's Stock Oversights: How to Profit With This Unconventional Investment Strategy
- Healthcare Stock Watch: My Short List of Booming (and Busting) Companies
- Legends Are Born Behind This Closed-Door Healthcare Conference
Marc Lichtenfeld’s investment newsletters and trading services:
- Editor, Access Research
- Healthcare Specialist, The White Cap Research Group
What Marc Lichtenfeld is working on right now:
Just recently, Marketocracy – a leading research company that tracks, analyzes, and evaluates the investment industry – released statistics showing Marc Lichtenfeld’s biotech portfolio outperformed 99.9% of the other 60,000 portfolios on their site.
Whether it’s a biotech, pharmaceutical or medical device company, I know how to pick winners.
In fact, in the worst bear market in 70 years, my picks at Access Research Group have actually made gains since 2007 – crushing the S&P 500 by nearly 50 percentage points. Find out how…
More from Marc Lichtenfeld
What was the first dollar you ever earned?
Shoveling snow when I was 9.
What’s been the most satisfying dollar (or dollars) you’ve ever earned?
It’s a tie. There was the $300 I made buying my first stock, when I was 22 – I bought 50 shares of Harley Davidson at $18 and sold it a short time later at $24. I thought this stock market stuff was going to be easy. The other one was being paid by Don King to ring announce one of his shows.
What’s your favorite way to make money?
Finding stocks that Wall Street has not yet discovered or misunderstands is one of my favorites.
What’s the best investing advice you’ve given or ever heard?
Zig when others zag.
Additional Articles
You can view previous articles by Marc Lichtenfeld below, or explore the Investment U archives.
- Wall Street's Stock Oversights: How to Profit With This Unconventional Investment Strategy
- Healthcare Stock Watch: My Short List of Booming (and Busting) Companies
- Legends Are Born Behind This Closed-Door Healthcare Conference
- Small-Cap Biotech Stocks: Why This Sector Is Set for a Huge Year
- Here's Why I'm Right About Gold Heading to $1,000... And Why You're Wrong!
- The Winners and Losers from a New U.S. Healthcare Reform Bill
- Take Profits on Gold: The Media's Dead Wrong About This Market
- As The Bulls Run Wild... Here Are Three Ways to Protect Your Profits
- Undervalued Stocks: These Three Stocks Are on "Blue Plate Special"
- Overvalued Stocks: Don't Touch These Bloated Investments With a 10-Foot Pole
- Investing in the Biotech Sector: Here's An Easy Way to Profit from Biotech Stocks
- The Stock Market's Red Flags: Four Ways to Handle Potential Market Turmoil
- The F.I.R.S.T. System: Searching For the "Holy Grail" of Investing
- Your Investment Portfolio: Crucial Investment Habits Every Investor Should Cultivate
- The Next Big Thing in Health Care: How to Profit From Immunotherapy & Regenerative Medicine
|
Check out our selection of daily Investment Research:
 |
 |
Investment U RSS Feed